
Ohio State hematologist Dr. Kerry Rogers says chemotherapy and newer targeted drugs both work well, and the right choice depends on the patient.
Clinical trials are essential in improving treatment in the world of oncology, especially for rare cancers.
Ghassan Abou-Alfa, M.D., a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the basics of clinical trials, and why participation in them is important.
Clinical trials play a vital role in moving the field of oncology forward. They assesses the safety of a drug, how effective it is in treating the disease and how it works compared to the current standard of care. Since some rarer cancers — like fibrolamellar cancer – do not have standards of care, phase 1 and phase 2 trials will suffice, and patient participation can be even more important.






